As of 2026-09-18, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (18.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 131.87 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -114.0%.
The range of the Relative Valuation is (12.09) - (15.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 35.3x | 31.0x |
| Forward P/E multiples | 16.5x - 21.8x | 21.6x |
| Fair Price | (12.09) - (15.25) | (18.44) |
| Upside | -109.2% - -111.6% | -114.0% |
| Date | P/E |